PropertyValue
?:abstract
  • As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined that the incidence of lymphopenia increased in COVID-19 and there was a significant relationship between lymphopenia and mortality. This can be thought of as an unresponsive problem in how to maintain anti-cancer drugs that cause lymphopenia. This article was written for a hypothetical approach in cancer patients diagnosed with COVID-19 in order to be an idea of collecting data for treatment with anti-cancer drugs that cause lymphopenia.
?:creator
?:doi
  • 10.1007/s12032-020-01376-8
?:doi
?:journal
  • Med_Oncol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/2017f87ed68c35e28c380e8196a897f6b72e006b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7180657.xml.json
?:pmcid
?:pmid
?:pmid
  • 32333196.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
?:type
?:year
  • 2020-04-24

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/cir8naow>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/cir8naow>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all